Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model

Because of their high specificity and low side effects, protein drugs possess a substantial global market. However, the low bioavailability of protein is still a major obstacle to their expanded applications, which is expected to be answered with proper protein formulations. Taking corneal neovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, H., Tang, B., Huang, W., Luo, S., Zhang, T., Yuan, J., Zheng, Q., Zan, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569714/
https://www.ncbi.nlm.nih.gov/pubmed/34765961
http://dx.doi.org/10.1016/j.mtbio.2021.100143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569714/
https://www.ncbi.nlm.nih.gov/pubmed/34765961
http://dx.doi.org/10.1016/j.mtbio.2021.100143

Ejemplares similares